东营癫痫医院哪儿有(山东济南那家医院治疗癫痫) (今日更新中)

TOWSON, Md. — Home videos capture images of Deborah Limmer and her 5-year-old granddaughter, Delaney Gaddis, which now serve as painful reminders of two lives lost, leaving the young girl's father searching for words to describe 241

The US economy added only 75,000 jobs in May, a surprisingly low number that was well below what experts had predicted.Meanwhile, the unemployment rate remained at 3.6%, meaning that joblessness is still hovering near a half-century low.The report supports suspicions that the labor market is finally slowing down from its blistering pace in 2018, with revisions to the past two months subtracting 75,000 jobs. Employers have added 164,000 jobs per month on average in 2019, compared with 223,000 jobs per month last year.Still, economists had expected 185,000 jobs added in May, so 75,000 fell far short of those expectations.The share of people who have jobs or are looking for them remained the same, suggesting that the low number may stem from the difficulty of finding workers after 104 months of continuous job creation. The share of people who can't find enough hours or stopped looking for work because they couldn't find a job decreased to 7.1%, nearing the lowest level on record, 6.8% in October 2000.Wage growth also decelerated slightly, with average hourly earnings rising 3.1% from a year earlier, down from a 3.2% rate a month earlier.Health care and professional and business services were singular bright spots in the report, and have added nearly 900,000 jobs over the past year between them.But construction, mining and manufacturing showed little change from April. Manufacturing has been particularly weak over the past several months, and measures of business confidence in the sector have reached cycle lows as President Donald Trump threatens new tariffs on Mexico. 1603

The president signed a trade agreement with China on Wednesday that is expected to boost exports from U.S. farmers and manufacturers and ease trade tensions between the two countries going into November’s presidential election. President Donald Trump is describing an initial trade agreement with China as “righting the wrongs of the past and delivering a future of economic justice and security for American workers, farmers and families." Trump promoted the signing as a way of delivering economic justice for American workers.However, the "Phase 1" agreement will do little to force China to make major economic changes, such as reducing unfair subsidies for its own companies that the Trump administration sought when it started the trade war by imposing tariffs on Chinese imports in July 2018, 812

The U.S. Food and Drug Administration is warning dog owners of a possible link between certain dog food brands and a serious form of canine heart disease.The 169

The University of Missouri-Kansas City has filed a lawsuit against a former professor, alleging that he stole and sold his graduate student's research for .5 million.The suit, filed this week, says Ashim Mitra swiped a "groundbreaking" drug formulation from the student and stands to gain as much as million more in royalties.Mitra, who has resigned from the university, denied the allegations to CNN.Also named in the lawsuit are Mitra's wife, who worked in her husband's lab, and two pharmaceutical companies that used the invention.The university alleges Mitra worked in secret with the companies to develop the patent, which outlines an innovative way of delivering drugs to the eye using nanotechnologyThe pharmaceutical product has recently received FDA approval, the university said. It's a treatment for dry eye, an ailment common to the elderly.The university's contentionIn a statement to CNN, the university said:"Mitra stole UMKC-owned inventions, sold them to industry, assisted those companies in patenting and commercializing them, denied credit to a deserving student and reaped a personal financial windfall -- all the while concealing his efforts and denying his involvement."The lawsuit seeks to designate the student, Kishore Cholkar, as the rightful inventor to the patent based on his research from 2010.The university policy is that it owns the rights to discoveries made by staff and students while they are working at the university. When commercial rewards are reaped, the inventor is entitled to one-third of the profits and the school keeps the remaining two-thirds, the school said.The professor's reactionReached by phone Thursday, the professor denied the allegations and told CNN that Cholkar doesn't deserve credit for the patent."Everyone is trying to jump in and get a piece of the pie," he said.He said he conceived of the formulation with the drug companies through his private consultancy business, adding that "the student arrived after the patent was signed."Cholkar's work involved a part of the eye not affected by the drug, Mitra said.He added that he's consulting with his lawyers on how best to tackle the lawsuit.Cholkar, the student, now works at a California-based pharmaceutical company. CNN has reached out to Cholkar for comment. 2298

来源：资阳报